Follow-up with 18FDG-PET–CT after radical radiotherapy with or without chemotherapy allows the detection of potentially curable progressive disease in non-small cell lung cancer patients: A prospective study

This publication has 41 references indexed in Scilit:

• Outcomes of Adrenalectomy for Isolated Synchronous Versus Metachronous Adrenal Metastases in Non–Small-Cell Lung Cancer: A Systematic Review and Pooled Analysis
  Journal of Clinical Oncology, 2008
• Cancer Statistics, 2008
  CA: A Cancer Journal for Clinicians, 2008
• The maximum uptake of 18F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1α and GLUT-1 in non-small cell lung cancer
  European Journal Of Cancer, 2007
• Metabolic (FDG–PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure
  Lung Cancer, 2005
• New Guidelines to Evaluate the Response to Treatment in Solid Tumors
  JNCI Journal of the National Cancer Institute, 2000
• Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer
  European Respiratory Journal, 1999
• Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations
  European Journal Of Cancer, 1999
• Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography.
  American Journal of Roentgenology, 1997
• Should patients with post-resection locoregional recurrence of lung cancer receive aggressive therapy?
  International Journal of Radiation Oncology*Biology*Physics, 1992
• Patterns of Failure in Patients with Resected Stage I and II Non-Small-cell Carcinoma of the Lung
  Annals of Surgery, 1987